Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 256

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Microwave Ablation for Hepatic Malignancies: A Multiinstitutional Analysis

Groeschl, Ryan T., Pilgrim, Charles H. C., Hanna, Erin M., Simo, Kerri A., Swan, Ryan Z., Sindram, David, Martinie, John B., Iannitti, David A., Bloomston, Mark, Schmidt, Carl, Khabiri, Hooman, Shirley, Lawrence A., Martin, Robert C. G., Tsai, Susan, Turaga, Kiran K., Christians, Kathleen K., Rilling, William S., Gamblin, T. Clark·2014·Annals of Surgery

Abstract

OBJECTIVE: This study hypothesized that tumor size, number of tumors, surgical approach, and tumor histology significantly affected microwave ablation (MWA) success and recurrence-free survival. BACKGROUND: Although many hepatobiliary centers have adopted MWA, the factors that influence local control are not well described. METHODS: Consecutive patients with hepatic malignancy treated by MWA were included from 4 high-volume institutions (2003-2011) and grouped by histology: hepatocellular carcinoma (HCC), colorectal liver metastases, neuroendocrine liver metastases, and other cancers. Independent significance of outcome variables was established with logistic regression and Cox proportional hazards models. RESULTS: Four hundred fifty patients were treated with 473 procedures (139 HCC, 198 colorectal liver metastases, 61 neuroendocrine liver metastases, and 75 other) for a total of 875 tumors. Median follow-up was 18 months. Concurrent hepatectomy was performed in 178 patients (38%), and when performed was associated with greater morbidity. Complete ablation was confirmed for 839 of 865 tumors (97.0%) on follow-up cross-sectional imaging (10 were unevaluable). A surgical approach (open, laparoscopic, or percutaneous) had no significant impact on complication rates, recurrence, or survival. The local recurrence rate was 6.0% overall and was highest for HCC (10.1%, P = 0.045) and percutaneously treated lesions (14.1%, P = 0.014). In adjusted models, tumor size 3 cm or more predicted poorer recurrence-free survival (hazard ratio: 1.60, 95% CI: 1.02-2.50, P = 0.039). CONCLUSIONS: In this large data set, patients with 3 cm or more tumors showed a propensity for early recurrence, regardless of histology. Higher rates of local recurrence were noted in HCC patients, which may reflect underlying liver disease. There were no significant differences in morbidity or survival based on the surgical approach; however, local recurrence rates were highest for percutaneously ablated tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0000000000000234

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 256

Metadata

Authors
Groeschl, R. T., Pilgrim, C. H. C., Hanna, E. M., Simo, K. A., Swan, R. Z., Sindram, D., Martinie, J. B., Iannitti, D. A., Bloomston, M., Schmidt, C., Khabiri, H., Shirley, L. A., Martin, R. C. G., Tsai, S., Turaga, K. K., Christians, K. K., Rilling, W. S., & Gamblin, T. C.
Venue
Annals of Surgery
Published
2014-06
Volume
259
Issue
6
Pages
1195-1200
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2046559051
Cited by
256
References
13
FWCI
12.48
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microwave Ablation for Hepatic Malignancies: A Multiinstitutional Analysis. https://app.cochat.ai/papers/10.1097/sla.0000000000000234
The paper
Groeschl, R. T., Pilgrim, C. H. C., Hanna, E. M., Simo, K. A., Swan, R. Z., Sindram, D., Martinie, J. B., Iannitti, D. A., Bloomston, M., Schmidt, C., Khabiri, H., Shirley, L. A., Martin, R. C. G., Tsai, S., Turaga, K. K., Christians, K. K., Rilling, W. S., & Gamblin, T. C. (2014). Microwave Ablation for Hepatic Malignancies: A Multiinstitutional Analysis. Annals of Surgery. https://doi.org/10.1097/sla.0000000000000234

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.